Today BMJ STI honours World Human T-cell Leukaemia Virus (HTLV) Day. More than 40 years ago, before the discovery of HIV, Bob Gallo and his team discovered HTLV-1, an oncovirus and the first recognised human retrovirus. An estimated 5-10 million individuals have been exposed to infection with HTLV type-1 globally, with specific hyperendemic regions (1). […]
Latest articles
From the Editor’s Desk – Highlights of the September Issue of Sexually Transmitted Infections
Editor’s choice: Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May–July 2019, UK Why does it matter? Investigators used an online community survey to study the prevalence and factors associated with self-prescribed STI prophylaxis among HIV PrEP users. Self-prescribing was reported by ~ […]
COVID-19 and People living with HIV – Revisited
Impact of HIV infection on COVID-19 clinical outcome In June 2020, STI shared a podcast describing the first available data about the outcomes of COVID-19 related hospitalisation for people living with HIV (PLWH). We shared some take-home points: 1) Encourage disclosure of known HIV status on COVID-19 related hospital admittance 2) Encourage HIV testing […]
Highlights of the August 2021 issue
Editor’s Choice: – Ways to improve knowledge of HIV and STIs among young MSM Why does it matter? Young MSM are at risk of HIV and STIs and poor knowledge is one recognised determinant. Researchers in Ireland tell us that knowledge regarding HIV and STI transmission, testing and treatment among MSM is modulated by […]
World Hepatitis Day 2021
STI World Hepatitis Day Podcast In the last decade, direct-acting antivirals have revolutionised hepatitis C treatment. With curative rates in excess of 90%, in 2016 the World Health Organization (WHO) announced the ambitious target of international hepatitis C virus elimination by 2030, aiming to prevent the estimated 400,000 people who die each year from HCV-related […]
HPV Vaccine Uptake: Challenges and Opportunities
Welcome to the fourth episode of the STI BMJ 2021 Podcast series. Please join Dr. Fabiola Martin in interviewing Professors Anna Maria Geretti, Carlo Giaquinto, and Ian Frazer about human papillomavirus vaccines and vaccination programmes. The first HPV vaccine was approved in 2006. Fifteen years later, more than 100 countries have added the vaccine […]
COVID-19 Vaccine and People with HIV
Welcome to the third episode of the 2021 BMJ STI podcast series! As you listen to this podcast, globally thousands of people will receive a dose of SARS-CoV-2 vaccine along with hope for the future. In this podcast, we will explore the main classes of COVID-19 vaccine and issues pertinent to the administration of […]
HIV epidemic in Indonesia: Are we there yet?
In this the second STI podcast of 2021, we focus on the HIV epidemic in Indonesia and how the country strives to meet the UNAIDS 90-90-90 UNAIDS sustainability goals for people living with HIV (PLWH). Episode Highlights: Indonesia is a densely populated country spread over 17,000 islands of stunning beauty. It has one of the […]
Trans and Gender Diverse People and Health Care Services
We begin the 2021 BMJ STI Podcast series with the first episode focusing on Trans and gender diverse people and health care services. We consider the question: Why do health care services need to adapt and promote provision of inclusive and non-discriminatory care independent of gender and sexual preference? In June 2020, the New Yorker […]
STI highlights U=U for World AIDS Day!
We bring you a 3-part series of podcasts dedicated to the World AIDS Day 2020 where we address the topic of U=U – an undetectable viral load equals untransmittable infection. We ask the question: Does the way we choose to inform people with HIV about U=U improve their quality life? What other research is […]